Skip to Main Content

Paper Details

High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
PLoS One
12
2017
Author NameAffiliation
Melissa SaulUniversity of Pittsburgh
  • 1 - 1

Datasets

Release 1.2